Amotosalen-HCl-UVA pathogen reduction does not alter poststorage metabolism of soluble CD40 ligand, Ox40 ligand and interkeukin-27, the cytokines that generally associate with serious adverse events

Vox Sanguinis

Volumn 108, Issue 2, 2015, Pages 205-207

  Hamzeh Cognasse, H ^a   Laradi, S ^a,b   Osselaer, J C ^c   Cognasse, F ^a,b   Garraud, O ^a,d  

^a UNIVERSITÉ DE LYON   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c Service Regional Vaudois de Transfusion Sanguine   (Switzerland)

^d INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

Cytokine; Inflammation; Pathogen reduction treatment; Platelet storage

Indexed keywords

AMOTOSALEN; CD40 LIGAND; CYTOKINE; INTERLEUKIN 27; OX40 LIGAND; FUROCOUMARIN DERIVATIVE;

ARTICLE; BLOOD STORAGE; BLOOD TRANSFUSION; CYTOKINE RELEASE; PRIORITY JOURNAL; ULTRAVIOLET A RADIATION; ADVERSE EFFECTS; BLOOD SAFETY; DRUG EFFECTS; HUMAN; METABOLISM; PROCEDURES; RADIATION RESPONSE; THROMBOCYTE; THROMBOCYTE TRANSFUSION; ULTRAVIOLET RADIATION;

BLOOD PLATELETS; BLOOD SAFETY; CD40 LIGAND; FUROCOUMARINS; HUMANS; OX40 LIGAND; PLATELET TRANSFUSION; ULTRAVIOLET RAYS;

EID: 84921033138     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12203     Document Type: Article

References (10)

1. Osselaer JC, Messe N, Hervig T, et al.: A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment. Transfusion 2008; 48:1061-1071
2. Cognasse F, Osselaer JC, Payrat JM, et al.: Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment. Transfusion 2008; 48:809-813
3. Lin L, Dikeman R, Molini B, et al.: Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion 2004; 44:1496-1504
4. Hamzeh-Cognasse H, Damien P, Nguyen KA, et al.: Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions. Transfusion 2014; 54:613-625
5. Lin L, Cook DN, Wiesehahn GP, et al.: Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997; 37:423-435
6. Hervig T, Seghatchian J, Apelseth TO: Current debate on pathogen inactivation of platelet concentrates-to use or not to use? Transfus Apher Sci 2010; 43:411-414
7. Vetlesen A, Mirlashari MR, Akkok CA, et al.: Biological response modifiers in photochemically pathogen-reduced versus untreated apheresis platelet concentrates. Transfusion 2013; 53:147-155
8. Hechler B, Ohlmann P, Chafey P, et al.: Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation. Transfusion 2013; 53:1187-1200
9. Jackman RP, Muench MO, Heitman JW, et al.: Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice. Transfusion 2013; 53:2697-2709
10. Cook RJ, Heddle NM: Clinical trials evaluating pathogen-reduced platelet products: methodologic issues and recommendations. Transfusion 2013; 53:1843-1855